醋酸烯诺孕酮/乙炔雌二醇

醋酸烯诺孕酮/乙炔雌二醇
	乙炔雌二醇（上方） ; 醋酸烯诺孕酮（下方）
组成
醋酸烯诺孕酮	孕酮
乙炔雌二醇	雌激素
临床资料
商品名（英语：Drug nomenclature）	Annovera
其他名称	EE/SGA; EE/SA
AHFS/Drugs.com	专业药物信息
MedlinePlus	a604032
核准状况	美 DailyMed: Segesterone_acetate_and_ethinyl_estradiol;
给药途径	阴道内给药
ATC码	未分配;
法律规范状态
法律规范	美：处方药（℞-only）;
识别信息
KEGG	D11654;

醋酸烯诺孕酮/乙炔雌二醇（EE/SGA），品牌药名称为Annovera，是一种阴道避孕环，使用复方激素避孕，成分包含醋酸烯诺孕酮、孕激素、炔雌醇及雌激素。^[1]^[2]^[3]当中炔雌醇含量为17.4毫克，醋酸烯诺孕酮为103毫克，平均每天会释放出13微克炔雌醇及0.15毫克醋酸烯诺孕酮。^[1]^[4]

Annovera需插入并放置在阴道21天，然后取出清洗并存放7天，在此期间使用者会有经期（撤出性出血），重复13次，共使用一年。^[5]Annovera与阴道避孕药环NuvaRing不同，Annovera使用前不需冷藏，可储存在高达30摄氏度的环境。^[1]

此药物由国际非牟利组织人口委员会开发，授权TherapeuticsMD制造。2018年8月，美国批准使用此药物作医疗用途。^[4]^[6]

参见

参考文献

^ ^1.0 ^1.1 ^1.2 ^1.3 Annovera- segesterone acetate and ethinyl estradiol ring. DailyMed. 7 August 2020 [10 October 2020]. （原始内容存档于2021-03-29）. "Annovera- segesterone acetate and ethinyl estradiol ring" （页面存档备份，存于互联网档案馆）. DailyMed. 7 August 2020. Retrieved 10 October 2020.
^ Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method. Expert Review of Clinical Pharmacology. October 2019, 12 (10): 953–963. PMID 31526281. doi:10.1080/17512433.2019.1669448.
^ Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. American Family Physician. May 2020, 101 (10): 618–620. PMID 32412221.
^ ^4.0 ^4.1 TherapeuticsMD Inc (新闻稿). 缺少或|title=为空 (帮助)
^ U.S. Food and Drug Administration (FDS) (新闻稿). 缺少或|title=为空 (帮助)
^ Drug Approval Package: Annovera (segesterone acetate and ethinyl estradiol). U.S. Food and Drug Administration (FDA). 10 September 2018 [10 October 2020]. （原始内容存档于2022-03-23）.

外部链接

Segesterone acetate. Drug Information Portal. U.S. National Library of Medicine.
Ethinylestradiol. Drug Information Portal. U.S. National Library of Medicine. [2022-03-23]. （原始内容存档于2021-04-21）.

[Annovera_FDA_label-1] 1.0 ^1.1 ^1.2 ^1.3 Annovera- segesterone acetate and ethinyl estradiol ring. DailyMed. 7 August 2020 [10 October 2020]. （原始内容存档于2021-03-29）. "Annovera- segesterone acetate and ethinyl estradiol ring" （页面存档备份，存于互联网档案馆）. DailyMed. 7 August 2020. Retrieved 10 October 2020.

[Nelson_2019-2] Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method. Expert Review of Clinical Pharmacology. October 2019, 12 (10): 953–963. PMID 31526281. doi:10.1080/17512433.2019.1669448.

[Lee_2020-3] Segesterone Acetate and Ethinyl Estradiol Vaginal Ring (Annovera) for Contraception. American Family Physician. May 2020, 101 (10): 618–620. PMID 32412221.

[TherapeuticsMD2018-4] 4.0 ^4.1 TherapeuticsMD Inc (新闻稿). 缺少或|title=为空 (帮助)

[5] U.S. Food and Drug Administration (FDS) (新闻稿). 缺少或|title=为空 (帮助)

[6] Drug Approval Package: Annovera (segesterone acetate and ethinyl estradiol). U.S. Food and Drug Administration (FDA). 10 September 2018 [10 October 2020]. （原始内容存档于2022-03-23）.

[1]

[2]

[3]

[4]

[5]

[6]